Table 3.
Effects of ipratropium bromide and combined intervention on mental condition of COPD patients.
| Group | Cases (n) | HAMA | HAMD | ||
|---|---|---|---|---|---|
| BT | AT | BT | AT | ||
| Control | 20 | 15.6 ± 4.24 | 15.3 ± 3.24f | 14.6 ± 3.40 | 13.3 ± 2.82cf |
| Ipratropium bromide | 24 | 16.0 ± 4.57 | 7.65 ± 3.50ad | 14.9 ± 4.15 | 8.64 ± 2.36ad |
| Combined intervention | 24 | 15.4 ± 4.15 | 6.37 ± 2.15bd | 13.9 ± 3.25 | 8.12 ± 2.06ad |
BT, before treatment; AT, after treatment; compared with the control group, aP < 0.05, bP < 0.01; compared with itself before treatment, cP < 0.05, dP < 0.01; compared with the ipratropium bromide group, fP < 0.01.